Literature DB >> 31868235

Transport of trans-activator of transcription (TAT) peptide in tumour tissue model: evaluation of factors affecting the transport of TAT evidenced by flow cytometry.

Aziz Ur Rahman1,2, Shahzeb Khan2, Munasib Khan2.   

Abstract

OBJECTIVES: Trans-activator of transcription (TAT), a cell penetrating peptide, has been explored to overcome resistance to penetration and transport inside the cell, therefore, suggested to be used as drug delivery vector into drug-resistant tumours. The generosity of this study was to evaluate modifiable factors (concentration, temperature, incubation time and spheroid age) on the penetration of TAT.
METHODS: Multicellular tumour spheroids (MCTS) used as tumour tissue models to mimic some characteristics with in-vivo tumors. Cell monolayer and 3-, 5-, 7-day-old MCTS were incubated with TAT and effects of modifiable factors were determined quantitatively through flow cytometry, based on TAT-positive cell count (%) and mean fluorescence intensity. KEY
FINDINGS: Enhancing TAT concentration (1, 5 and 25 µm), transport significantly increased (ANOVA, P < 0.0001) in cell monolayer and spheroids. However, rising temperature from 7 to 37°C (t, P > 0.05) and increasing incubation time; 20 min, 1 h and 3 h; (ANOVA, P > 0.05) were statistically non-significant. Moreover, TAT penetration declines as spheroids get older (ANOVA, P < 0.01).
CONCLUSION: While exploiting MCTS as tumour tissue model, older spheroids could be preferred to target penetration-resistant cells and mimic the in-vivo microenvironment.
© 2019 Royal Pharmaceutical Society.

Entities:  

Keywords:  HT-29 cell line; TAT peptide; cell penetrating peptides; flow cytometry; multicellular tumour spheroids

Year:  2019        PMID: 31868235     DOI: 10.1111/jphp.13221

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  A brain glioma gene delivery strategy by angiopep-2 and TAT-modified magnetic lipid-polymer hybrid nanoparticles.

Authors:  Lanxin Qiao; Yu Qin; Yaxin Wang; Yi Liang; Dunwan Zhu; Wei Xiong; Lu Li; Di Bao; Linhua Zhang; Xu Jin
Journal:  RSC Adv       Date:  2020-11-13       Impact factor: 4.036

Review 2.  Nanotechnology Advances in the Detection and Treatment of Cancer: An Overview.

Authors:  Sareh Mosleh-Shirazi; Milad Abbasi; Mohammad Reza Moaddeli; Ahmad Vaez; Mostafa Shafiee; Seyed Reza Kasaee; Ali Mohammad Amani; Saeid Hatam
Journal:  Nanotheranostics       Date:  2022-08-21

Review 3.  Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and Prospects.

Authors:  Hui Zu; Danchen Gao
Journal:  AAPS J       Date:  2021-06-02       Impact factor: 4.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.